ÂÜÀòÂÒÂ×

Joshua Schultz is an accomplished executive with extensive experience in leadership roles within the healthcare and pharmaceutical sectors. As Operating Partner at Arsenal Capital Partners, Schultz brings strategic insight and operational expertise. Previously, as CEO of Cytel, Schultz led initiatives that advanced the company's growth and market presence. At PAREXEL, Schultz served in multiple executive capacities, including Senior Vice President and Corporate Vice President for both Late Phase and Strategic Partnerships, where leadership contributed to significant business development and partnerships. Additionally, Schultz held the position of VP Corporate Development at Veritas Medicine, further solidifying a strong background in corporate strategy and development.